Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen.

导出 LinkOut

翻译打印收藏纠错

第一作者： Han Kyu,Chae

第一单位： Department of Urology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, South Korea.

作者： Han Kyu,Chae ^[1] ; Wook,Nam ^[1] ; Han Gwun,Kim ^[1] ; Sharon,Lim ^[2] ; Byeong-Joo,Noh ^[2] ; So Won,Kim ^[3] ; Gil Hyun,Kang ^[2] ; Jong Yeon,Park ^[1] ; Dae-Woon,Eom ^[2] ; Sung Jin,Kim ^[1]

作者单位： Department of Urology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, South Korea. ^[1] Department of Pathology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, South Korea. ^[2] Department of Parmacology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. ^[3]

关键词 ADC (antibody-drug conjugate)BCG (Bacillus Calmette–Guérin)CD8 HER2 (human epidermal growth factor receptor-2)PD-L1 PD1 ki67

主题词卡介苗(BCG Vaccine);人类(Humans);Ki-67抗原(Ki-67 Antigen);肿瘤复发, 局部(Neoplasm Recurrence, Local);预后(Prognosis);肿瘤微环境(Tumor Microenvironment);膀胱肿瘤(Urinary Bladder Neoplasms)

DOI 10.3389/fimmu.2022.903297

PMID 35677058

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交